Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Comparative analysis of therapeutic options used for myasthenia gravis.

Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A.

Ann Neurol. 2010 Dec;68(6):797-805. doi: 10.1002/ana.22139.

PMID:
21061395
[PubMed - indexed for MEDLINE]
2.

The incidence of myasthenia gravis: a systematic literature review.

McGrogan A, Sneddon S, de Vries CS.

Neuroepidemiology. 2010;34(3):171-83. doi: 10.1159/000279334. Epub 2010 Feb 2. Review.

PMID:
20130418
[PubMed - indexed for MEDLINE]
3.

Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.

Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, Latov N, Quick A, Tandan R.

Muscle Nerve. 2009 Nov;40(5):890-900. doi: 10.1002/mus.21433. Review.

PMID:
19768755
[PubMed - indexed for MEDLINE]
4.

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ.

Neurology. 2009 May 5;72(18):1548-54. doi: 10.1212/WNL.0b013e3181a41211.

PMID:
19414721
[PubMed - indexed for MEDLINE]
5.

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.

Zinman L, Ng E, Bril V.

Neurology. 2007 Mar 13;68(11):837-41.

PMID:
17353471
[PubMed - indexed for MEDLINE]
6.

The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.

Sullivan PW, Arant TW, Ellis SL, Ulrich H.

Pharmacoeconomics. 2006;24(10):1021-33.

PMID:
17002484
[PubMed - indexed for MEDLINE]
7.

Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.

Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S; Myasthenia Gravis Clinical Study Group.

Arch Neurol. 2005 Nov;62(11):1689-93.

PMID:
16286541
[PubMed - indexed for MEDLINE]
8.

Myasthenic crisis: clinical features, complications and mortality.

Murthy JM, Meena AK, Chowdary GV, Naryanan JT.

Neurol India. 2005 Mar;53(1):37-40; discussion 40.

PMID:
15805653
[PubMed - indexed for MEDLINE]
Free Article
9.

Plasma exchange in France: Epidemiology 2001.

Korach JM, Petitpas D, Paris B, Bourgeade F, Passerat V, Berger P, Chillet P; French Registry Study Group.

Transfus Apher Sci. 2003 Oct;29(2):153-7.

PMID:
12941355
[PubMed - indexed for MEDLINE]
10.

The clinical features of 16 cases of stroke associated with administration of IVIg.

Caress JB, Cartwright MS, Donofrio PD, Peacock JE Jr.

Neurology. 2003 Jun 10;60(11):1822-4.

PMID:
12796539
[PubMed - indexed for MEDLINE]
11.

Plasma exchange for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2002;(4):CD002275. Review.

PMID:
12519572
[PubMed - indexed for MEDLINE]
12.

Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis.

R√łnager J, Ravnborg M, Hermansen I, Vorstrup S.

Artif Organs. 2001 Dec;25(12):967-73.

PMID:
11843764
[PubMed - indexed for MEDLINE]
13.

The six year experience of plasmapheresis in patients with myasthenia gravis.

Chiu HC, Chen WH, Yeh JH.

Ther Apher. 2000 Aug;4(4):291-5.

PMID:
10975476
[PubMed - indexed for MEDLINE]
14.

Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.

Qureshi AI, Choudhry MA, Akbar MS, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA, Krendel DA, Leshner RT.

Neurology. 1999 Feb;52(3):629-32.

PMID:
10025801
[PubMed - indexed for MEDLINE]
15.

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.

Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C.

Ann Neurol. 1997 Jun;41(6):789-96.

PMID:
9189040
[PubMed - indexed for MEDLINE]
16.

The utility of therapeutic plasmapheresis for neurological disorders.

[No authors listed]

Natl Inst Health Consens Dev Conf Consens Statement. 1986;6(4):1-7. Review. No abstract available.

PMID:
3537747
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk